# EDGAR Filing Document

**Accession Number:** 0001631569
**File Stem:** 0001631569-26-000027
**Filing Date:** 2026-5
**Character Count:** 111948
**Document Hash:** e18d281127b3c1caf25edb6e83b126b5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001631569-26-000027.hdr.sgml**: 20260505

**ACCESSION NUMBER**: 0001631569-26-000027

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 26

**CONFORMED PERIOD OF REPORT**: 20260505

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260505

**DATE AS OF CHANGE**: 20260505

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Community Healthcare Trust Inc
- **CENTRAL INDEX KEY:** 0001631569
- **STANDARD INDUSTRIAL CLASSIFICATION:** REAL ESTATE INVESTMENT TRUSTS [6798]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 465212033
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37401
- **FILM NUMBER:** 26943476

**BUSINESS ADDRESS:**
- **STREET 1:** 3326 ASPEN GROVE DRIVE
- **STREET 2:** SUITE 150
- **CITY:** FRANKLIN
- **STATE:** TN
- **ZIP:** 37067
- **BUSINESS PHONE:** 615-771-3052

**MAIL ADDRESS:**
- **STREET 1:** 3326 ASPEN GROVE DRIVE
- **STREET 2:** SUITE 150
- **CITY:** FRANKLIN
- **STATE:** TN
- **ZIP:** 37067

?xml version='1.0' encoding='ASCII'? chct-20260505

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of report (Date of earliest event reported): May 5, 2026

**COMMUNITY HEALTHCARE TRUST INCORPORATED**

(Exact Name of Registrant as Specified in its Charter)

---

| | | |
|:---|:---|:---|
| **Maryland** | **001-37401** | **46-5212033** |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer<br>Identification No.) |

---

**3326 Aspen Grove Drive, Suite 150, Franklin, Tennessee 37067** 

(Address of principal executive offices) (Zip Code)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(615) 771-3052** 

(Registrant's telephone number, including area code)

**Not Applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| <u>Title of each Class</u> | <u>Trading Symbol</u> | <u>Name of each exchange on which registered</u> |
| Common stock, $0.01 par value per share | CHCT | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02**&nbsp;&nbsp;&nbsp;&nbsp;**Results of Operations and Financial Condition**

On May 5, 2026, Community Healthcare Trust Incorporated (the "Company") issued a press release announcing its earnings for the first quarter ended March 31, 2026. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety.

This information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act.

**Item 7.01 Regulation FD Disclosure**

The Company is furnishing its Supplemental Information for the first quarter ended March 31, 2026, which is also contained on its website (<u>www.chct.reit)</u>. See Exhibit 99.2 to this Current Report on Form 8-K.

The Company has prepared an investor presentation for the first quarter ended March 31, 2026 that is expected to be used in meetings with current and potential investors. A copy of this presentation is available on the Company's website (<u>www.chct.reit</u>).

This information furnished pursuant to this Item 7.01, including Exhibit 99.2, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act.

**Item 9.01 Financial Statements and Exhibits**

The exhibits required by Item 601 of Regulation S-K which are filed with this report are listed in the Exhibit Index and are hereby incorporated in by reference.

------

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | <u>[Press release dated](earningspressrelease2026q1.htm) May 5, 2026</u> |
| 99.2 | <u>[Supplemental Information -](supplementalinfo2026q1.htm)First Quarter 2026</u>  |
| 104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document) |

---

------

**SIGNATURE**

&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | COMMUNITY HEALTHCARE TRUST INCORPORATED | COMMUNITY HEALTHCARE TRUST INCORPORATED |
| | By: | /s/ William G. Monroe IV |
| | | William G. Monroe IV |
| | | Executive Vice President and Chief Financial Officer |
| May 5, 2026 |  |  |

---

## Exhibit 99.1

Exhibit 99.1

News Release

Community Healthcare Trust Announces Results for the Three Months Ended March 31, 2026

FRANKLIN, Tenn., May 5, 2026 / PRNewswire / -- Community Healthcare Trust Incorporated (NYSE: CHCT) (the "Company") today announced results for the three months ended March 31, 2026. The Company reported net income for the three months ended March 31, 2026 of approximately $2.5 million, or $0.07 per diluted common share. Funds from operations ("FFO") and adjusted funds from operations ("AFFO") for the three months ended March 31, 2026 totaled $0.49 and $0.56 per diluted common share, respectively.

**Items Impacting Our Results include:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• During the first quarter of 2026, the Company acquired an inpatient rehabilitation facility in Florida upon completion of construction for a purchase price and cash consideration of approximately $28.5 million. The property was 100.0% leased to a tenant with a lease expiration in 2044 and an expected return of approximately 9.3%. The acquisition was funded with net proceeds from the Revolving Credit Facility and asset sales.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• During the first quarter of 2026, the Company disposed of one property and received net proceeds of approximately $5.2 million. The Company also received net proceeds of approximately $0.7 million for a property disposed of during the fourth quarter of 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• During the first quarter of 2026, the geriatric behavioral hospital operator, a tenant in six of the Company's properties, paid $0.3 million in rent, an increase of $0.1 million from the fourth quarter of 2025. In July 2025, the tenant signed a Letter of Intent (LOI) for the sale of its business to a behavioral healthcare provider. The buyer is finalizing legal and business due diligence and has entered the drafting phase of the definitive purchase documents, including new leases on the six hospitals owned by the Company. While the transaction is progressing, the Company cannot provide assurance regarding the specific timing or the ultimate certainty of the closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***•*** The Company has four properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $99.0 million. The Company's expected returns on these investments are approximately 9.1% to 9.75%. The Company anticipates closing on these properties throughout 2026 and 2027; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** During the first quarter of 2026, the Company did not issue any shares under its ATM program.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** On April 30, 2026, the Company's Board of Directors declared a quarterly common stock dividend in the amount of $0.48 per share. The dividend is payable on May 22, 2026 to stockholders of record on May 11, 2026.

**About Community Healthcare Trust Incorporated**

Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. As of March 31, 2026, the Company had investments of approximately $1.2 billion in 198 real estate properties (including one property with sales-type leases). The properties are located in 36 states, totaling approximately 4.5 million square feet in the aggregate.

Additional information regarding the Company, including this quarter's operations, can be found at <u>www.chct.reit</u>. Please contact the Company at 615-771-3052 to request a printed copy of this information.

------

***Cautionary Note Regarding Forward-Looking Statements***

*In addition to the historical information contained within, the matters discussed in this press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identifiable by use of forward-looking terminology such as "believes", "expects", "may", "will," "should", "seeks", "approximately", "intends", "plans", "estimates", "anticipates" or other similar words or expressions, including the negative thereof. Forward-looking statements are based on certain assumptions and can include future expectations, future plans and strategies, financial and operating projections or other forward-looking information. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management. Because forward-looking statements relate to future events, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the control of Community Healthcare Trust Incorporated (the "Company"). Thus, the Company's actual results and financial condition may differ materially from those indicated in such forward-looking statements. Some factors that might cause such a difference include the following: general volatility of the capital markets and the market price of the Company's common stock, changes in the Company's business strategy, availability, terms and deployment of capital, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, changes in governmental regulations, the degree and nature of the Company's competition, the ability to consummate acquisitions under contract, catastrophic or extreme weather and other natural events and the physical effects of climate change, the occurrence of cyber incidents, effects on global and national markets as well as businesses resulting from increased inflation, changes in interest rates, supply chain disruptions, labor conditions, prolonged government shutdown or budgetary reductions or impasses, tariffs and global trade tensions, and/or international conflicts, and the other factors described in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and the Company's other filings with the Securities and Exchange Commission from time to time. Readers are therefore cautioned not to place undue reliance on the forward-looking statements contained herein which speak only as of the date hereof. The Company intends these forward-looking statements to speak only as of the time of this press release and undertakes no obligation to update forward-looking statements, whether as a result of new information, future developments, or otherwise, except as may be required by law.*

------

**COMMUNITY HEALTHCARE TRUST INCORPORATED**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

***(Dollars and shares in thousands, except per share amounts)***

---

| | | |
|:---|:---|:---|
| | ***(Unaudited)*** | |
| | **March 31, 2026** |<br>**December 31, 2025** |
| **ASSETS** | | |
| **Real estate properties:** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land and land improvements | $162587 | $154673 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buildings, improvements, and lease intangibles | 1074680 | 1047743 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Personal property | 813 | 813 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties | 1238080 | 1203229 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less accumulated depreciation | (290958) | (280316) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties, net | 947122 | 922913 |
| Cash and cash equivalents | 2617 | 3340 |
| Assets held for sale |  | 5265 |
| Other assets, net | 60354 | 59239 |
| **Total assets** | $1010093 | $990757 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| **Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debt, net | $559260 | $532199 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | 16431 | 14925 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities, net | 13059 | 14246 |
| **Total liabilities** | 588750 | 561370 |
| Commitments and contingencies |  |  |
| **Stockholders' Equity** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, $0.01 par value; 50,000 shares authorized; none issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.01 par value; 450,000 shares authorized; 28,572 and 28,471 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively  | 286 | 285 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 719819 | 717450 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cumulative net income | 93325 | 90777 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive gain | 7395 | 6691 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cumulative dividends | (399482) | (385816) |
| **Total stockholders' equity** | 421343 | 429387 |
| **Total liabilities and stockholders' equity** | $1010093 | $990757 |

---

The Consolidated Balance Sheets do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

------

**COMMUNITY HEALTHCARE TRUST INCORPORATED**

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME**

**FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025**

***(Dollars and shares in thousands, except per share amounts)***

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
|  | *(Unaudited)* | *(Unaudited)* |
| **REVENUES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rental income | $31269 | $29730 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating interest | 255 | 348 |
|  | 31524 | 30078 |
| **EXPENSES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property operating | 6369 | 6095 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 5108 | 5100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 10657 | 10943 |
|  | 22134 | 22138 |
| **OTHER (EXPENSE) INCOME** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on the sale of real estate assets | (46) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (6799) | (6352) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest and other income, net | 3 | 3 |
|  | (6842) | (6349) |
| **NET INCOME** | $2548 | $1591 |
| **NET INCOME PER COMMON SHARE** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income per common share - Basic | $0.07 | $0.03 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income per common share - Diluted | $0.07 | $0.03 |
| **WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC** | 26991 | 26733 |
| **WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED** | 26991 | 26733 |

---

The Consolidated Statements of Income do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

------

**COMMUNITY HEALTHCARE TRUST INCORPORATED**

**RECONCILIATION OF FFO and AFFO** <sup>(1)</sup>

***(Unaudited; Dollars and shares in thousands, except per share amounts)***

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Net income | $2548 | $1591 |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate depreciation and amortization | 10805 | 11077 |
| &nbsp;&nbsp;&nbsp;Loss on the sale of real estate assets | 46 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total adjustments | 10851 | 11077 |
| FFO <sup>(1)(2)</sup> | $13399 | $12668 |
| &nbsp;&nbsp;&nbsp;&nbsp;Straight-line rent | (760) | (639) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 2711 | 2710 |
| AFFO <sup>(1)(2)</sup> | $15350 | $14739 |
| &nbsp;&nbsp;&nbsp;&nbsp;**FFO per Common Share-Diluted** <sup>(1)(2)</sup> | $**0.49** | $**0.47** |
| &nbsp;&nbsp;&nbsp;&nbsp;**AFFO per Common Share-Diluted** <sup>(1)(2)</sup> | $**0.56** | $**0.55** |
| Weighted Average Common Shares Outstanding-Diluted <sup>(2)</sup> | 27570 | 27007 |

---

(1) Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or fallen with market conditions, many industry investors deem presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. For that reason, the Company considers funds from operations ("FFO") and adjusted funds from operations ("AFFO") to be appropriate measures of operating performance of an equity real estate investment trust ("REIT"). In particular, the Company believes that AFFO is useful because it allows investors, analysts and Company management to compare the Company's operating performance to the operating performance of other real estate companies and between periods on a consistent basis without having to account for differences caused by unanticipated items and other events. <br> The Company uses the National Association of Real Estate Investment Trusts, Inc. ("NAREIT") definition of FFO. FFO is an operating performance measure adopted by NAREIT. NAREIT defines FFO as the most commonly accepted and reported measure of a REIT's operating performance equal to net income (calculated in accordance with GAAP), excluding gains or losses from the sale of certain real estate assets, gains and losses from change in control, impairment write-downs of certain real estate assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity, plus depreciation and amortization related to real estate properties, and after adjustments for unconsolidated partnerships and joint ventures. NAREIT also provides REITs with an option to exclude gains, losses and impairments of assets that are incidental to the main business of the REIT from the calculation of FFO. <br> In addition to FFO, the Company presents AFFO and AFFO per share. The Company defines AFFO as FFO, excluding certain expenses related to closing costs of properties acquired accounted for as business combinations and mortgages funded, excluding straight-line rent and the amortization of stock-based compensation, and including or excluding other non-cash items from time to time. AFFO presented herein may not be comparable to similar measures presented by other real estate companies due to the fact that not all real estate companies use the same definition. <br> FFO and AFFO should not be considered as alternatives to net income (determined in accordance with GAAP) as indicators of the Company's financial performance or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are they necessarily indicative of sufficient cash flow to fund all of the Company's needs. The Company believes that in order to facilitate a clear understanding of the consolidated historical operating results of the Company, FFO and AFFO should be examined in conjunction with net income as presented elsewhere herein.

(2) Diluted weighted average common shares outstanding for FFO and AFFO are calculated based on the treasury method, rather than the 2-class method used to calculate earnings per share. Restricted stock awards and time-based RSUs are included in the calculation of weighted average common shares outstanding to the extent that they are dilutive. Performance-based RSUs are included in the calculation of weighted average common shares outstanding to the extent that they are in-the-money as of the end of the reporting period and are dilutive. <br>

CONTACT: Bill Monroe, 615-771-3052

SOURCE: Community Healthcare Trust Incorporated

## Exhibit 99.2

Exhibit 99.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ![chctlogo.jpg](chctlogo.jpg) | **CHCT** |
| ![chctlogo.jpg](chctlogo.jpg) | LISTED |
| ![chctlogo.jpg](chctlogo.jpg) | **NYSE** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

![prairiestar1.jpg](prairiestar1.jpg)

**SUPPLEMENTAL INFORMATION**<br>**Q1 2026**<br>

![a6701rocksiderdphotos-0959.jpg](a6701rocksiderdphotos-0959.jpg)

---

| | |
|:---|:---|
| **Community Healthcare Trust** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**ABOUT US**

    

CHCT is a self-managed healthcare real estate investment trust ("REIT") that owns a diverse portfolio of properties including medical office buildings, acute inpatient behavioral facilities, inpatient rehabilitation facilities, physician clinics, specialty centers, behavioral specialty facilities, and surgical centers and hospitals across the United States, primarily outside of urban centers. As a result of favorable demographic trends, increases in healthcare spending, and the shift in the delivery of healthcare services to community-based facilities, we believe our properties are essential for healthcare providers to serve their local markets.

**TABLE OF CONTENTS**

    

---

| | |
|:---|:---|
| [Company Snapshot](#ie664121e6cdd4fe5beed14d1ffae10cb_7) | [3](#ie664121e6cdd4fe5beed14d1ffae10cb_7) |
| [Corporate Information](#ie664121e6cdd4fe5beed14d1ffae10cb_10) | [4](#ie664121e6cdd4fe5beed14d1ffae10cb_10) |
| [Financial Highlights](#ie664121e6cdd4fe5beed14d1ffae10cb_13) | [5](#ie664121e6cdd4fe5beed14d1ffae10cb_13) |
| [Consolidated Balance Sheets](#ie664121e6cdd4fe5beed14d1ffae10cb_16) | [7](#ie664121e6cdd4fe5beed14d1ffae10cb_16) |
| [Consolidated Statements of Operations](#ie664121e6cdd4fe5beed14d1ffae10cb_19) | [8](#ie664121e6cdd4fe5beed14d1ffae10cb_19) |
| [Reconciliation of Non-GAAP Measures](#ie664121e6cdd4fe5beed14d1ffae10cb_22) | [9](#ie664121e6cdd4fe5beed14d1ffae10cb_22) |
| [Weighted Average Shares](#ie664121e6cdd4fe5beed14d1ffae10cb_25) | [11](#ie664121e6cdd4fe5beed14d1ffae10cb_25) |
| [Debt Summary](#ie664121e6cdd4fe5beed14d1ffae10cb_28) | [12](#ie664121e6cdd4fe5beed14d1ffae10cb_28) |
| [Investment Activity](#ie664121e6cdd4fe5beed14d1ffae10cb_31) | [13](#ie664121e6cdd4fe5beed14d1ffae10cb_31) |
| Portfolio[Diversification](#ie664121e6cdd4fe5beed14d1ffae10cb_34) | [14](#ie664121e6cdd4fe5beed14d1ffae10cb_34) |
| [Lease Expirations](#ie664121e6cdd4fe5beed14d1ffae10cb_37) | [15](#ie664121e6cdd4fe5beed14d1ffae10cb_37) |
| [Property Locations](#ie664121e6cdd4fe5beed14d1ffae10cb_40) | [16](#ie664121e6cdd4fe5beed14d1ffae10cb_40) |
| [Reporting Definitions](#ie664121e6cdd4fe5beed14d1ffae10cb_43) | [24](#ie664121e6cdd4fe5beed14d1ffae10cb_43) |
| [Disclaimers](#ie664121e6cdd4fe5beed14d1ffae10cb_46) | [27](#ie664121e6cdd4fe5beed14d1ffae10cb_46) |

---

---

| | |
|:---|:---|
| **Community Healthcare Trust** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**COMPANY SNAPSHOT**

    

---

| | |
|:---|:---|
| | **March 31, 2026** |
| Gross real estate investments (in thousands) <sup>(1)</sup> | $1246149 |
| Total properties | 198 |
| % Leased | 89.8% |
| Total square feet owned | 4535753 |
| Weighted Average remaining lease term (years) | 7.2 |
| Cash and cash equivalents (in thousands) | $2617 |
| Debt to Total Capitalization | 44.0% |
| Interest rate per annum on Revolving Line of Credit | 5.3% |
| Weighted average interest rate per annum on Term Loans <sup>(2)</sup> | 4.7% |
| Equity market cap (in millions) | $454.0 |
| Quarterly dividend paid in the period (per share) | $0.4775 |
| Quarter end stock price (per share) | $15.89 |
| Dividend yield | 12.0% |
| Common shares outstanding | 28571793 |
| ___________ |  |
| <sup>(1)</sup> Includes one property with sales-type leases.  | <sup>(1)</sup> Includes one property with sales-type leases.  |
| <sup>(2)</sup> Term Loans are fully hedged; this rate represents the weighted average hedged rates. | <sup>(2)</sup> Term Loans are fully hedged; this rate represents the weighted average hedged rates. |

---

![chart-26dd2190ae55436f9ba.jpg](chart-26dd2190ae55436f9ba.jpg)

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 3** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**CORPORATE INFORMATION**

    

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Community Healthcare Trust Incorporated** | **Community Healthcare Trust Incorporated** | **Community Healthcare Trust Incorporated** | **Community Healthcare Trust Incorporated** | **Community Healthcare Trust Incorporated** | **Community Healthcare Trust Incorporated** |
| 3326 Aspen Grove Drive, Suite 150 | 3326 Aspen Grove Drive, Suite 150 | 3326 Aspen Grove Drive, Suite 150 | 3326 Aspen Grove Drive, Suite 150 | 3326 Aspen Grove Drive, Suite 150 | 3326 Aspen Grove Drive, Suite 150 |
| Franklin, TN 37067 | Franklin, TN 37067 | Franklin, TN 37067 | Franklin, TN 37067 | Franklin, TN 37067 | Franklin, TN 37067 |
| Phone: 615-771-3052 | Phone: 615-771-3052 | Phone: 615-771-3052 | Phone: 615-771-3052 | Phone: 615-771-3052 | Phone: 615-771-3052 |
| E-mail: Investorrelations@chct.reit | E-mail: Investorrelations@chct.reit | E-mail: Investorrelations@chct.reit | E-mail: Investorrelations@chct.reit | E-mail: Investorrelations@chct.reit | E-mail: Investorrelations@chct.reit |
| Website: www.chct.reit | Website: www.chct.reit | Website: www.chct.reit | Website: www.chct.reit | Website: www.chct.reit | Website: www.chct.reit |
| **BOARD OF DIRECTORS** | **BOARD OF DIRECTORS** | **BOARD OF DIRECTORS** | **BOARD OF DIRECTORS** | **BOARD OF DIRECTORS** |  |
| **Alan Gardner** | **Robert Hensley** | **Claire Gulmi** | **R. Lawrence Van Horn** | **Cathrine Cotman** | **David H. Dupuy** |
| Chairman of the <br>Board | Audit Committee <br>Chair | Compensation Committee <br>Chair | ESG Committee <br>Chair | Board <br>member | Board <br>member |

---

---

| | | |
|:---|:---|:---|
| **EXECUTIVE MANAGEMENT TEAM** | **EXECUTIVE MANAGEMENT TEAM** | **EXECUTIVE MANAGEMENT TEAM** |
| **David H. Dupuy** | **William G. Monroe IV** | **Leigh Ann Stach** |
| Chief Executive Officer <br>and President | Executive Vice President<br>Chief Financial Officer | Executive Vice President<br>Chief Accounting Officer |

---

---

| | |
|:---|:---|
| **COVERING ANALYSTS** | **COVERING ANALYSTS** |
| A. Goldfarb - Piper Sandler | M. Lewis - Truist Securities |
| J. Kammert - Evercore ISI | B. Oxford - Colliers International Securities |
| **PROFESSIONAL SERVICES** | **PROFESSIONAL SERVICES** |
| **Independent Registered Public Accounting Firm** | **Transfer Agent** |
| BDO USA, P.C. | Equiniti Trust Company, LLC |
| 501 Commerce Street, Suite 1400 | Operations Center |
| Nashville, TN 37203 | 6201 15<sup>th</sup> Avenue |
|  | Brooklyn, NY 11219 |
|  | 1-800-937-5449 |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 4** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**FINANCIAL HIGHLIGHTS**

    

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **1Q 2026** | **4Q 2025** | **3Q 2025** | **2Q 2025** | **1Q 2025** |
|  | *(Unaudited and in thousands, except per share data)* | *(Unaudited and in thousands, except per share data)* | *(Unaudited and in thousands, except per share data)* | *(Unaudited and in thousands, except per share data)* | *(Unaudited and in thousands, except per share data)* |
| **STATEMENTS OF OPERATIONS ITEMS** <sup>(1)(2)(3)(4)</sup> |  |  |  |  |  |
| Revenues | $31524 | $30946 | $31086 | $29085 | $30078 |
| Net income (loss) | $2548 | $14428 | $1640 | $(12557) | $1591 |
| NOI | $25155 | $24932 | $25156 | $23500 | $23983 |
| EBITDA*re* | $20050 | $20173 | $20505 | $4274 | $18886 |
| Adjusted EBITDA*re* | $22761 | $22772 | $22970 | $20068 | $21596 |
| FFO | $13399 | $13329 | $13547 | $6336 | $12668 |
| AFFO | $15350 | $14943 | $15099 | $13585 | $14739 |
| Per Diluted Share: <sup>(1)(2)(3)(4)</sup> |  |  |  |  |  |
| Net income (loss) attributable to common shareholders  | $0.07 | $0.51 | $0.03 | $(0.50) | $0.03 |
| FFO | $0.49 | $0.49 | $0.50 | $0.23 | $0.47 |
| AFFO | $0.56 | $0.55 | $0.56 | $0.50 | $0.55 |
| ___________ |  |  |  |  |  |
| (1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share. | (1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share. | (1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share. | (1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share. | (1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share. | (1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share. |
| (2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share, FFO, and AFFO. | (2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share, FFO, and AFFO. | (2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share, FFO, and AFFO. | (2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share, FFO, and AFFO. | (2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share, FFO, and AFFO. | (2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share, FFO, and AFFO. |
| (3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business. | (3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business. | (3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business. | (3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business. | (3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business. | (3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business. |
| (4) Net loss and FFO for the second quarter of 2025 included severance and transition-related charges totaling approximately $5.9 million, including approximately $4.6 million of non-cash accelerated amortization of stock-based compensation, which reduced FFO per diluted common share by approximately $0.22. | (4) Net loss and FFO for the second quarter of 2025 included severance and transition-related charges totaling approximately $5.9 million, including approximately $4.6 million of non-cash accelerated amortization of stock-based compensation, which reduced FFO per diluted common share by approximately $0.22. | (4) Net loss and FFO for the second quarter of 2025 included severance and transition-related charges totaling approximately $5.9 million, including approximately $4.6 million of non-cash accelerated amortization of stock-based compensation, which reduced FFO per diluted common share by approximately $0.22. | (4) Net loss and FFO for the second quarter of 2025 included severance and transition-related charges totaling approximately $5.9 million, including approximately $4.6 million of non-cash accelerated amortization of stock-based compensation, which reduced FFO per diluted common share by approximately $0.22. | (4) Net loss and FFO for the second quarter of 2025 included severance and transition-related charges totaling approximately $5.9 million, including approximately $4.6 million of non-cash accelerated amortization of stock-based compensation, which reduced FFO per diluted common share by approximately $0.22. | (4) Net loss and FFO for the second quarter of 2025 included severance and transition-related charges totaling approximately $5.9 million, including approximately $4.6 million of non-cash accelerated amortization of stock-based compensation, which reduced FFO per diluted common share by approximately $0.22. |

---

![chart-1b6d8ed0880f453188a.jpg](chart-1b6d8ed0880f453188a.jpg)![chart-f5507fd31d79476090d.jpg](chart-f5507fd31d79476090d.jpg)

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 5** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**FINANCIAL HIGHLIGHTS (Continued)**

    

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **As of** | **As of** | **As of** | **As of** | **As of** |
| | **1Q 2026** | **4Q 2025** | **3Q 2025** | **2Q 2025** | **1Q 2025** |
|  | *(Unaudited and dollars in thousands)* | *(Unaudited and dollars in thousands)* | *(Unaudited and dollars in thousands)* | *(Unaudited and dollars in thousands)* | *(Unaudited and dollars in thousands)* |
| **BALANCE SHEET ITEMS** |  |  |  |  |  |
| **ASSETS** |  |  |  |  |  |
| Total real estate properties | $1238080 | $1203229 | $1190151 | $1158312 | $1148772 |
| Total assets | $1010093 | $990757 | $987261 | $966292 | $985114 |
| **CAPITALIZATION** |  |  |  |  |  |
| Net debt | $559260 | $532199 | $530138 | $500077 | $496016 |
| Total capitalization | $1271561 | $1241902 | $1229442 | $1200858 | $1210874 |
| Net debt/total capitalization | 44.0% | 42.9% | 43.1% | 41.6% | 41.0% |
| Market valuation | $454006 | $467501 | $435613 | $471766 | $514631 |
| Enterprise value | $1010649 | $996360 | $962368 | $966980 | $1008376 |

---

![chart-fff29575a8e64d71bd1.jpg](chart-fff29575a8e64d71bd1.jpg)

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 6** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**CONSOLIDATED BALANCE SHEETS**

    

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **As of** | **As of** | **As of** | **As of** | **As of** |
| | **1Q 2026** | **4Q 2025** | **3Q 2025** | **2Q 2025** | **1Q 2025** |
| **ASSETS** | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* |
| **Real estate properties** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land and land improvements | $162587 | $154673 | $154272 | $152887 | $149506 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buildings, improvements, and lease intangibles | 1074680 | 1047743 | 1035070 | 1004616 | 998933 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Personal property | 813 | 813 | 809 | 809 | 333 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties | 1238080 | 1203229 | 1190151 | 1158312 | 1148772 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less accumulated depreciation | (290958) | (280316) | (272481) | (262961) | (253537) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total real estate properties, net | 947122 | 922913 | 917670 | 895351 | 895235 |
| Cash and cash equivalents | 2617 | 3340 | 3383 | 4863 | 2271 |
| Assets held for sale, net |  | 5265 | 6205 | 5465 | 6755 |
| Other assets, net | 60354 | 59239 | 60003 | 60613 | 80853 |
| **Total assets** | $1010093 | $990757 | $987261 | $966292 | $985114 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |  |  |  |
| **Liabilities** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debt, net | $559260 | $532199 | $530138 | $500077 | $496016 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | 16431 | 14925 | 17205 | 13944 | 12058 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities, net | 13059 | 14246 | 13095 | 14451 | 15719 |
| **Total liabilities** | 588750 | 561370 | 560438 | 528472 | 523793 |
| Commitments and contingencies |  |  |  |  |  |
| **Stockholders' Equity** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, $0.01 par value; 50,000 shares authorized |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.01 par value; 450,000 shares authorized | 286 | 285 | 285 | 284 | 283 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 719819 | 717450 | 714890 | 712498 | 706776 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cumulative net income  | 93325 | 90777 | 76349 | 74709 | 87266 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive gain | 7395 | 6691 | 7568 | 9121 | 12402 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cumulative dividends | (399482) | (385816) | (372269) | (358792) | (345406) |
| **Total stockholders' equity** | 421343 | 429387 | 426823 | 437820 | 461321 |
| **Total liabilities and stockholders' equity** | $1010093 | $990757 | $987261 | $966292 | $985114 |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 7** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**CONSOLIDATED STATEMENTS OF OPERATIONS**

    

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **1Q 2026** | **4Q 2025** | **3Q 2025** | **2Q 2025** | **1Q 2025** |
|  | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* |
| **REVENUES** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rental income | $31269 | $30679 | $30814 | $30128 | $29730 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating interest | 255 | 267 | 272 | (1043) | 348 |
|  | 31524 | 30946 | 31086 | 29085 | 30078 |
| **EXPENSES** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property operating | 6369 | 6014 | 5930 | 5585 | 6095 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative <sup>(1)(2)</sup> | 5108 | 4778 | 4658 | 10559 | 5100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 10657 | 10814 | 10902 | 10879 | 10943 |
|  | 22134 | 21606 | 21490 | 27023 | 22138 |
| **OTHER (EXPENSE) INCOME** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Loss) gain, net of impairment, on the sale of real estate assets | (46) | 12051 | (888) | 640 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (6799) | (6959) | (7075) | (6592) | (6352) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Credit loss reserve |  |  |  | (8672) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax expense |  | (23) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest and other income, net | 3 | 19 | 7 | 5 | 3 |
|  | (6842) | 5088 | (7956) | (14619) | (6349) |
| **NET INCOME (LOSS)** | $2548 | $14428 | $1640 | $(12557) | $1591 |
| **NET INCOME (LOSS) PER DILUTED COMMON SHARE** | $0.07 | $0.51 | $0.03 | $(0.50) | $0.03 |
| **WEIGHTED AVERAGE COMMON SHARES OUTSTANDING** | 26991 | 26953 | 26934 | 26803 | 26733 |
| **DIVIDENDS DECLARED, PER COMMON SHARE, IN THE PERIOD** | $0.4775 | $0.4750 | $0.4725 | $0.4700 | $0.4675 |
| (1) **GENERAL AND ADMINISTRATIVE EXPENSES:** | (1) **GENERAL AND ADMINISTRATIVE EXPENSES:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash vs. Cash: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-cash (stock-based compensation) | 53.1% | 54.4% | 52.9% | 54.3% | 53.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash | 46.9% | 45.6% | 47.1% | 45.7% | 46.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;As a % of Revenue: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-cash (stock-based compensation) | 8.6% | 8.4% | 8.0% | 8.7% | 9.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash | 7.6% | 7.0% | 7.1% | 7.3% | 7.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;(2) General and administrative expenses for the three months ended June 30, 2025 includes the accelerated amortization of stock-based compensation totaling $4.6 million and severance and transition related expense totaling $1.3 million, recognized upon a termination. These amounts are not included in the calculations above in footnote (1). | &nbsp;&nbsp;&nbsp;&nbsp;(2) General and administrative expenses for the three months ended June 30, 2025 includes the accelerated amortization of stock-based compensation totaling $4.6 million and severance and transition related expense totaling $1.3 million, recognized upon a termination. These amounts are not included in the calculations above in footnote (1). | &nbsp;&nbsp;&nbsp;&nbsp;(2) General and administrative expenses for the three months ended June 30, 2025 includes the accelerated amortization of stock-based compensation totaling $4.6 million and severance and transition related expense totaling $1.3 million, recognized upon a termination. These amounts are not included in the calculations above in footnote (1). | &nbsp;&nbsp;&nbsp;&nbsp;(2) General and administrative expenses for the three months ended June 30, 2025 includes the accelerated amortization of stock-based compensation totaling $4.6 million and severance and transition related expense totaling $1.3 million, recognized upon a termination. These amounts are not included in the calculations above in footnote (1). | &nbsp;&nbsp;&nbsp;&nbsp;(2) General and administrative expenses for the three months ended June 30, 2025 includes the accelerated amortization of stock-based compensation totaling $4.6 million and severance and transition related expense totaling $1.3 million, recognized upon a termination. These amounts are not included in the calculations above in footnote (1). | &nbsp;&nbsp;&nbsp;&nbsp;(2) General and administrative expenses for the three months ended June 30, 2025 includes the accelerated amortization of stock-based compensation totaling $4.6 million and severance and transition related expense totaling $1.3 million, recognized upon a termination. These amounts are not included in the calculations above in footnote (1). |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 8** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**RECONCILIATION OF NON-GAAP MEASURES**

    

**FUNDS FROM OPERATIONS (FFO)**

**ADJUSTED FUNDS FROM OPERATIONS (AFFO)** 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **1Q 2026** | **4Q 2025** | **3Q 2025** | **2Q 2025** | **1Q 2025** |
|  | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* |
| &nbsp;&nbsp;**NET INCOME (LOSS)**<sup>(1)(2)(3)(4)</sup> | $2548 | $14428 | $1640 | $(12557) | $1591 |
| Real estate depreciation and amortization | 10805 | 10952 | 11019 | 10861 | 11077 |
| Credit loss reserve |  |  |  | 8672 |  |
| Loss (gain), net of impairment, on the sale of real estate assets | 46 | (12051) | 888 | (640) |  |
| &nbsp;&nbsp;**FFO**<sup>(1)(3)</sup> | $13399 | $13329 | $13547 | $6336 | $12668 |
| Straight-line rent | (760) | (985) | (913) | (1184) | (639) |
| Stock-based compensation | 2711 | 2599 | 2465 | 2531 | 2710 |
| Accelerated amortization of stock-based compensation |  |  |  | 4591 |  |
| Severance and transition related expenses |  |  |  | 1311 |  |
| &nbsp;&nbsp;**AFFO**<sup>(2)(3)</sup> | $15350 | $14943 | $15099 | $13585 | $14739 |
| &nbsp;&nbsp;&nbsp;**FFO PER COMMON SHARE** | $**0.49** | $**0.49** | $**0.50** | $**0.23** | $**0.47** |
| &nbsp;&nbsp;&nbsp;**AFFO PER COMMON SHARE** | $**0.56** | $**0.55** | $**0.56** | $**0.50** | $**0.55** |
| &nbsp;&nbsp;&nbsp;**WEIGHTED AVERAGE COMMON SHARES OUTSTANDING** | 27570 | 27259 | 27195 | 27011 | 27007 |
| &nbsp;&nbsp;&nbsp;**<u>________________</u>** |  |  |  |  |  |
| (1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share. | (1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share. | (1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share. | (1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share. | (1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share. | (1) Net income for the fourth quarter of 2025 included net gains on sale, net of losses, totaling approximately $12.3 million, resulting in an increase of $0.46 per diluted share. |
| (2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share for net loss, FFO, and AFFO. | (2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share for net loss, FFO, and AFFO. | (2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share for net loss, FFO, and AFFO. | (2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share for net loss, FFO, and AFFO. | (2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share for net loss, FFO, and AFFO. | (2) Net loss, FFO and AFFO for the second quarter of 2025 included interest receivable reserves totaling approximately $1.7 million, resulting in a reduction of $0.06 per diluted share for net loss, FFO, and AFFO. |
| (3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business. | (3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business. | (3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business. | (3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business. | (3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business. | (3) Net loss for the second quarter of 2025 included an $8.7 million credit loss reserve related to notes receivable with a geriatric behavioral hospital tenant that are incidental to the Company's main business. |
| (4) Net loss and FFO for the second quarter of 2025 included severance and transition-related charges totaling approximately $5.9 million, including approximately $4.6 million of non-cash accelerated amortization of stock-based compensation, which reduced FFO per diluted common share by approximately $0.22. | (4) Net loss and FFO for the second quarter of 2025 included severance and transition-related charges totaling approximately $5.9 million, including approximately $4.6 million of non-cash accelerated amortization of stock-based compensation, which reduced FFO per diluted common share by approximately $0.22. | (4) Net loss and FFO for the second quarter of 2025 included severance and transition-related charges totaling approximately $5.9 million, including approximately $4.6 million of non-cash accelerated amortization of stock-based compensation, which reduced FFO per diluted common share by approximately $0.22. | (4) Net loss and FFO for the second quarter of 2025 included severance and transition-related charges totaling approximately $5.9 million, including approximately $4.6 million of non-cash accelerated amortization of stock-based compensation, which reduced FFO per diluted common share by approximately $0.22. | (4) Net loss and FFO for the second quarter of 2025 included severance and transition-related charges totaling approximately $5.9 million, including approximately $4.6 million of non-cash accelerated amortization of stock-based compensation, which reduced FFO per diluted common share by approximately $0.22. | (4) Net loss and FFO for the second quarter of 2025 included severance and transition-related charges totaling approximately $5.9 million, including approximately $4.6 million of non-cash accelerated amortization of stock-based compensation, which reduced FFO per diluted common share by approximately $0.22. |
| &nbsp;&nbsp;**AFFO, ADJUSTED FOR ACQUISITIONS** <sup>(1)</sup> |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**AFFO** | $15350 | $14943 | $15099 | $13585 | $14739 |
| Revenue on Properties Acquired in the period <sup>(2)</sup> | 422 | 510 | 62 | 122 |  |
| Property operating expense adjustment <sup>(2)</sup> | (63) | (67) | (8) |  |  |
| Interest expense adjustment <sup>(3)</sup> | (83) | (114) | (14) |  | (41) |
| &nbsp;&nbsp;&nbsp;**AFFO, ADJUSTED FOR ACQUISITIONS** | $15626 | $15272 | $15139 | $13707 | $14698 |
| (1) AFFO is adjusted to reflect acquisitions as if they had occurred on the first day of the applicable period. | (1) AFFO is adjusted to reflect acquisitions as if they had occurred on the first day of the applicable period. | (1) AFFO is adjusted to reflect acquisitions as if they had occurred on the first day of the applicable period. | (1) AFFO is adjusted to reflect acquisitions as if they had occurred on the first day of the applicable period. | (1) AFFO is adjusted to reflect acquisitions as if they had occurred on the first day of the applicable period. | (1) AFFO is adjusted to reflect acquisitions as if they had occurred on the first day of the applicable period. |
| (2) Revenue and expense adjustments are calculated based on expected returns and leases in place at acquisition. | (2) Revenue and expense adjustments are calculated based on expected returns and leases in place at acquisition. | (2) Revenue and expense adjustments are calculated based on expected returns and leases in place at acquisition. | (2) Revenue and expense adjustments are calculated based on expected returns and leases in place at acquisition. | (2) Revenue and expense adjustments are calculated based on expected returns and leases in place at acquisition. | (2) Revenue and expense adjustments are calculated based on expected returns and leases in place at acquisition. |
| (3) The interest expense adjustment was calculated using the weighted average interest rate on the Company's revolving credit facility. | (3) The interest expense adjustment was calculated using the weighted average interest rate on the Company's revolving credit facility. | (3) The interest expense adjustment was calculated using the weighted average interest rate on the Company's revolving credit facility. | (3) The interest expense adjustment was calculated using the weighted average interest rate on the Company's revolving credit facility. | (3) The interest expense adjustment was calculated using the weighted average interest rate on the Company's revolving credit facility. | (3) The interest expense adjustment was calculated using the weighted average interest rate on the Company's revolving credit facility. |
| &nbsp;&nbsp;&nbsp;**AMORTIZATION OF STOCK-BASED COMPENSATION** |  |  |  |  |  |
| &nbsp;&nbsp;Amortization Required by GAAP <sup>(1)(2)</sup> | $2711 | $2599 | $2465 | $2531 | $2710 |
| &nbsp;&nbsp;Amortization Based on Legal Vesting Periods <sup>(2)</sup> | 2155 | 2173 | 2122 | 2035 | 2208 |
| &nbsp;&nbsp;&nbsp;Acceleration of Amortization | $556 | $426 | $343 | $496 | $502 |
| (1) GAAP requires that deferred compensation be amortized over the earlier of the vesting or retirement eligibility date. | (1) GAAP requires that deferred compensation be amortized over the earlier of the vesting or retirement eligibility date. | (1) GAAP requires that deferred compensation be amortized over the earlier of the vesting or retirement eligibility date. | (1) GAAP requires that deferred compensation be amortized over the earlier of the vesting or retirement eligibility date. | (1) GAAP requires that deferred compensation be amortized over the earlier of the vesting or retirement eligibility date. | (1) GAAP requires that deferred compensation be amortized over the earlier of the vesting or retirement eligibility date. |
| (2) Amortization amounts for the second quarter of 2025 do not include the accelerated amortization of stock-based compensation totaling $4.6 million recognized upon a termination. | (2) Amortization amounts for the second quarter of 2025 do not include the accelerated amortization of stock-based compensation totaling $4.6 million recognized upon a termination. | (2) Amortization amounts for the second quarter of 2025 do not include the accelerated amortization of stock-based compensation totaling $4.6 million recognized upon a termination. | (2) Amortization amounts for the second quarter of 2025 do not include the accelerated amortization of stock-based compensation totaling $4.6 million recognized upon a termination. | (2) Amortization amounts for the second quarter of 2025 do not include the accelerated amortization of stock-based compensation totaling $4.6 million recognized upon a termination. | (2) Amortization amounts for the second quarter of 2025 do not include the accelerated amortization of stock-based compensation totaling $4.6 million recognized upon a termination. |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 9** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**RECONCILIATION OF NON-GAAP MEASURES (CONTINUED)**

    

**NET OPERATING INCOME (NOI)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **1Q 2026** | **4Q 2025** | **3Q 2025** | **2Q 2025** | **1Q 2025** |
| | (Unaudited; Dollars and shares in thousands, except per share data) | (Unaudited; Dollars and shares in thousands, except per share data) | (Unaudited; Dollars and shares in thousands, except per share data) | (Unaudited; Dollars and shares in thousands, except per share data) | (Unaudited; Dollars and shares in thousands, except per share data) |
| **NET OPERATING INCOME** |  |  |  |  |  |
| Net income (loss)<sup>(1)(2)</sup> | $2548 | $14428 | $1640 | $(12557) | $1591 |
| General and administrative<sup>(3)</sup> | 5108 | 4778 | 4658 | 4657 | 5100 |
| Accelerated amortization of deferred compensation |  |  |  | 4591 |  |
| Severance and transition-related compensation |  |  |  | 1311 |  |
| Depreciation and amortization | 10657 | 10814 | 10902 | 10879 | 10943 |
| Loss (gain), net of impairment, on the sales of real estate assets | 46 | (12051) | 888 | (640) |  |
| Credit loss reserve |  |  |  | 8672 |  |
| Interest expense | 6799 | 6959 | 7075 | 6592 | 6352 |
| Deferred Income tax expense |  | 23 |  |  |  |
| Interest and other income, net | (3) | (19) | (7) | (5) | (3) |
| **NOI** | $25155 | $24932 | $25156 | $23500 | $23983 |
| **EBITDA*re* and ADJUSTED EBITDA*re*** |  |  |  |  |  |
| **EBITDA*re*** |  |  |  |  |  |
| Net (loss) income <sup>(1)(2)</sup> | $2548 | $14428 | $1640 | $(12557) | $1591 |
| Interest expense | 6799 | 6959 | 7075 | 6592 | 6352 |
| Depreciation and amortization | 10657 | 10814 | 10902 | 10879 | 10943 |
| Deferred Income tax expense |  | 23 |  |  |  |
| Loss (gain), net of impairment, on the sale of real estate assets | 46 | (12051) | 888 | (640) |  |
| **EBITDA*re*** | $20050 | $20173 | $20505 | $4274 | $18886 |
| Non-cash stock-based compensation expense | 2711 | 2599 | 2465 | 2531 | 2710 |
| Accelerated amortization of stock-based compensation |  |  |  | 4591 |  |
| Credit loss reserve |  |  |  | 8672 |  |
| **ADJUSTED EBITDA*re*** | $22761 | $22772 | $22970 | $20068 | $21596 |
| **ADJUSTED EBITDA*re* ANNUALIZED** <sup>(4)</sup> | $91044 |  |  |  |  |

---

---

| |
|:---|
| (1) During the second quarter of 2025, the Company reversed interest totaling approximately $1.7 million related to a tenant. |
| (2) During the second quarter of 2025 the Company recorded severance and transition-related charges totaling approximately $5.9 million related to the termination of an employee, including approximately $4.6 of million non-cash accelerated amortization of stock-based compensation. |
| (3) Severance and transition-related compensation, which is included in general and administrative expenses on the income statement, is shown separately in the reconciliation above for the second quarter of 2025. |
| (4) Adjusted EBITDA*re* multiplied by 4. This annualized amount may differ significantly from the actual full year results. |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 10** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**WEIGHTED AVERAGE SHARES** 

    

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **1Q 2026** | **4Q 2025** | **3Q 2025** | **2Q 2025** | **1Q 2025** |
|  | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* | *(Unaudited; Dollars and shares in thousands, except per share data)* |
| **WEIGHTED AVERAGE COMMON SHARES OUTSTANDING (1)** |  |  |  |  |  |
| Weighted average common shares outstanding | 28556 | 28471 | 28430 | 28364 | 28324 |
| Unvested restricted shares | (1565) | (1518) | (1496) | (1561) | (1591) |
| Weighted average common shares outstanding - EPS | 26991 | 26953 | 26934 | 26803 | 26733 |
| Weighted average common shares outstanding - FFO Basic | 26991 | 26953 | 26934 | 26803 | 26733 |
| Potential dilutive common shares (from below) | 579 | 306 | 261 | 208 | 274 |
| Weighted average common shares outstanding - FFO Diluted | 27570 | 27259 | 27195 | 27011 | 27007 |
| **TREASURY SHARE CALCULATION** |  |  |  |  |  |
| Unrecognized deferred compensation-end of period | $17257 | $17665 | $19968 | $19919 | $25420 |
| Unrecognized deferred compensation-beginning of period | $17665 | $19968 | $19919 | $25420 | $25668 |
| Average unrecognized deferred compensation | $17461 | $18817 | $19944 | $22670 | $25544 |
| Average share price per share | $16.87 | $14.93 | $15.66 | $16.50 | $19.08 |
| Treasury shares | 1035 | 1260 | 1274 | 1374 | 1339 |
| Unvested restricted shares | (1565) | (1518) | (1496) | (1561) | (1591) |
| Unvested restricted share units | (49) | (48) | (39) | (21) | (22) |
| Treasury shares | 1035 | 1260 | 1274 | 1374 | 1339 |
| Potential dilutive common shares | 579 | 306 | 261 | 208 | 274 |
| (1) Restricted stock awards and time-based RSUs are included in the calculation of weighted average common shares outstanding if dilutive. Performance-based RSUs are included in the calculation of weighted average common shares outstanding to the extent that they in-the-money as of the end of the reporting period and are dilutive. | (1) Restricted stock awards and time-based RSUs are included in the calculation of weighted average common shares outstanding if dilutive. Performance-based RSUs are included in the calculation of weighted average common shares outstanding to the extent that they in-the-money as of the end of the reporting period and are dilutive. | (1) Restricted stock awards and time-based RSUs are included in the calculation of weighted average common shares outstanding if dilutive. Performance-based RSUs are included in the calculation of weighted average common shares outstanding to the extent that they in-the-money as of the end of the reporting period and are dilutive. | (1) Restricted stock awards and time-based RSUs are included in the calculation of weighted average common shares outstanding if dilutive. Performance-based RSUs are included in the calculation of weighted average common shares outstanding to the extent that they in-the-money as of the end of the reporting period and are dilutive. | (1) Restricted stock awards and time-based RSUs are included in the calculation of weighted average common shares outstanding if dilutive. Performance-based RSUs are included in the calculation of weighted average common shares outstanding to the extent that they in-the-money as of the end of the reporting period and are dilutive. | (1) Restricted stock awards and time-based RSUs are included in the calculation of weighted average common shares outstanding if dilutive. Performance-based RSUs are included in the calculation of weighted average common shares outstanding to the extent that they in-the-money as of the end of the reporting period and are dilutive. |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 11** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**DEBT SUMMARY**

    

---

| | | | |
|:---|:---|:---|:---|
| | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** |
| | **Principal <br>Balance** | **Stated <br>Rate** | **Hedged <br>Rate** |
|  | *(in thousands)* |  |  |
| Revolving credit facility <sup>(1)</sup> | $285000 | 5.33% | n/a |
| Term loan A-4 | 125000 |  | 3.60% |
| Term loan A-5 | 150000 |  | 5.61% |
| **Debt** | 560000 |  |  |
| Deferred Financing Costs, net | (740) |  |  |
| **Debt, net** | $559260 |  |  |

---

(1) Interest rate swaps previously entered into to fix the interest rates on the A-3 Term Loan were left in place on the Revolving Credit Facility through their maturity on March 29, 2026.

![chart-bf33c53037fb48f8a93.jpg](chart-bf33c53037fb48f8a93.jpg)

---

| | | |
|:---|:---|:---|
| **Select Covenants** | **Required** | **As of March 31, 2026** |
| Leverage ratio | ≤ 60.0% | 44.7% |
| Fixed charge coverage ratio | ≥ 1.50x | 2.9 |
| Tangible net worth (in thousands) | ≥ $504,476 | $692210 |
| Secured indebtedness | ≤ 30.0% | —% |
| Minimum debt service coverage ratio | ≥ 2.0 | 3.2 |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 12** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**2026 PROPERTY INVESTMENTS**

    

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Property** | **Market** | **Property <br>Type** | **Date <br>Acquired** | **% Leased at Acquisition** | **Purchase**<br> **Price** <br>*(in thousands)* | **Square Feet** |
| Nobis Rehabilitation Hospital | Pinellas Park, FL | IRF | 2/19/2026 | 100.0% | $28500 | 37151 |
|  |  |  |  | **100.0%** | $**28500** | **37151** |

---

![chart-1e7895305f1947b5bdb.jpg](chart-1e7895305f1947b5bdb.jpg)

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 13** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**PORTFOLIO DIVERSIFICATION**

    

![chart-9b5137074c524722a15.jpg](chart-9b5137074c524722a15.jpg)

---

| | |
|:---|:---|
| **Property Type** | **Annualized Rent (%)** |
| Medical Office Building (MOB) | 34.9% |
| Inpatient Rehabilitation Facilities (IRF) | 23.2% |
| Acute Inpatient Behavioral (AIB) | 12.4% |
| Physician Clinics (PC) | 8.3% |
| Specialty Centers (SC) | 8.2% |
| Behavioral Specialty Facilities (BSF) | 7.0% |
| Surgical Centers and Hospitals (SCH) | 4.0% |
| Long-term Acute Care Hospitals (LTACH) | 2.0% |
| **Total** | **100.0%** |

---

![chart-8dfc90c90ad8422b84e.jpg](chart-8dfc90c90ad8422b84e.jpg)

---

| | |
|:---|:---|
| **State** | **Annualized <br>Rent (%)** |
| Florida (FL) | 14.4% |
| Texas (TX) | 14.1% |
| Ohio (OH) | 9.5% |
| Illinois (IL) | 9.4% |
| Pennsylvania (PA) | 5.8% |
| All Others | 46.8% |
| **Total** | **100.0%** |

---

![chart-066b5683e45149b9bd5.jpg](chart-066b5683e45149b9bd5.jpg)

---

| | |
|:---|:---|
| **Tenant** | **Annualized <br>Rent (%)** |
| US Healthvest | 7.1% |
| Lifepoint Health (Lifepoint) | 6.3% |
| PAM Health (PAM) | 4.9% |
| Assurance Health (Assurance) | 2.9% |
| Summit Behavioral Healthcare (Summit) | 2.8% |
| UPMC - University of Pittsburgh Medical Center | 2.6% |
| Worcester Behavioral Innovations Hospital (Worcester) | 2.4% |
| Nobis Rehabilitation Partners | 2.3% |
| Exalt Health, LLC | 2.3% |
| Oceans Behavioral (Oceans) | 2.3% |
| All Others | 64.1% |
| **Total** | **100.0%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 14** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**LEASE EXPIRATIONS**

    

![chart-d5d62b323e814aef9d8.jpg](chart-d5d62b323e814aef9d8.jpg)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Total Leased Sq. Ft.** | **Total Leased Sq. Ft.** | **Annualized Rent** | **Annualized Rent** |
| **Year** | **Number of<br>Leases Expiring** | **Amount**<br>***(thousands)*** | **Percent (%)** | **Amount ($)**<br>***(thousands)*** | **Percent (%)** |
| 2026 | 57 | 329 | 8.1% | $7313 | 6.4% |
| 2027 | 71 | 386 | 9.5% | 8738 | 7.6% |
| 2028 | 72 | 485 | 11.9% | 10240 | 8.9% |
| 2029 | 46 | 375 | 9.2% | 9675 | 8.4% |
| 2030 | 36 | 294 | 7.2% | 6879 | 6.0% |
| 2031 | 33 | 410 | 10.1% | 11315 | 9.8% |
| 2032 | 24 | 201 | 4.9% | 3917 | 3.4% |
| 2033 | 15 | 85 | 2.1% | 1704 | 1.5% |
| 2034 | 20 | 260 | 6.4% | 9496 | 8.3% |
| 2035 | 16 | 233 | 5.7% | 8942 | 7.8% |
| Thereafter | 42 | 1003 | 24.6% | 36564 | 31.7% |
| Month-to-Month | 5 | 12 | 0.3% | 200 | 0.2% |
| **Totals** | **437** | **4073** | **100.0%** | $**114983** | **100.0%** |

---

Total portfolio was approximately 89.8% leased in the aggregate at March 31, 2026 with lease expirations ranging from 2026 through 2046.

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 15** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**PROPERTY LOCATIONS**

**<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>**

**Approximately 53% of our property revenues are in MSAs with populations over 1,000,000 and approximately 93% are in statistical areas with populations over 100,000.**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Property Name** | **Property Type** | **Area** | **% of Square Feet** | **Annualized<br> Rent ($000's)** | **% of Annualized<br> Rent** | **Population** | **MSA/MISA** | **Rank** |
| Lancaster MOB | MOB | 10098 | 0.22% | $313.8 | 0.27% | 12844441 | Los Angeles-Long Beach-Anaheim, CA | 2 |
| Congress Medical Building 350 | MOB | 17543 | 0.39% | $169.7 | 0.15% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| Congress Medical Building 390 | MOB | 30855 | 0.68% | $526.0 | 0.46% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| Future Diagnostics Group | SC | 8876 | 0.20% | $320.5 | 0.28% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| Gurnee Medical Office Building | MOB | 22968 | 0.51% | $174.8 | 0.15% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| New Lenox Medical Clinic | PC | 7905 | 0.17% | $347.8 | 0.30% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| Morris Medical Center | MOB | 18470 | 0.41% | $388.7 | 0.34% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| Oak Lawn Medical Plaza | MOB | 33356 | 0.74% | $466.8 | 0.41% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| Lincolnwood Medical Building | PC | 14863 | 0.33% | $323.4 | 0.28% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| Joliet Medical Building | SC | 44888 | 0.99% | $462.0 | 0.40% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| Endeavor Health | PC | 13700 | 0.30% | $284.3 | 0.25% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| Skin MD | PC | 13565 | 0.30% | $539.8 | 0.47% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| Chicago Behavioral Hospital | AIB | 85000 | 1.87% | $2270.7 | 1.97% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| US HealthVest - Lake | AIB | 83658 | 1.84% | $3054.1 | 2.66% | 9434123 | Chicago-Naperville-Elgin, IL-IN | 3 |
| Texas Rehabilitation Hospital of Fort Worth, LLC | IRF | 39761 | 0.88% | $2109.9 | 1.83% | 8477157 | Dallas-Fort Worth-Arlington, TX | 4 |
| Bayside Medical Center | MOB | 50593 | 1.12% | $1119.8 | 0.97% | 7904627 | Houston-Pasadena-The Woodlands, TX | 5 |
| Gessner Road MOB | MOB | 14347 | 0.32% | $368.2 | 0.32% | 7904627 | Houston-Pasadena-The Woodlands, TX | 5 |
| Clear Lake Institute for Rehabilitation | IRF | 55646 | 1.23% | $3137.2 | 2.73% | 7904627 | Houston-Pasadena-The Woodlands, TX | 5 |
| TRT Recovery Cartersville, LLC | BSF | 38339 | 0.85% | $1048.8 | 0.91% | 6482182 | Atlanta-Sandy Springs-Roswell, GA | 6 |
| Clinton Towers MOB | MOB | 37371 | 0.82% | $916.1 | 0.80% | 6465724 | Washington-Arlington-Alexandria, DC-VA-MD-WV | 7 |
| 2301 Research Boulevard | MOB | 93109 | 2.05% | $2282.9 | 1.99% | 6465724 | Washington-Arlington-Alexandria, DC-VA-MD-WV | 7 |
| Haddon Hill Professional Center | MOB | 25118 | 0.55% | $303.7 | 0.26% | 6329118 | Philadelphia-Camden-Wilmington, PA-NJ-DE-MD | 9 |
| Hopebridge - Westlake | BSF | 15057 | 0.33% | $239.2 | 0.21% | 6329118 | Philadelphia-Camden-Wilmington, PA-NJ-DE-MD | 9 |
| Continuum Wellness Center | MOB | 8227 | 0.18% | $169.6 | 0.15% | 5228938 | Phoenix-Mesa-Chandler, AZ | 10 |
| Virtuous Health Center | SCH | 11722 | 0.26% | $441.3 | 0.38% | 5228938 | Phoenix-Mesa-Chandler, AZ | 10 |
| Desert Mtn Health Center | BSF | 14046 | 0.31% | $647.2 | 0.56% | 5228938 | Phoenix-Mesa-Chandler, AZ | 10 |
| Associated Surgical Center of Dearborn | SCH | 12400 | 0.27% | $377.8 | 0.33% | 4390913 | Detroit-Warren-Dearborn, MI | 14 |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 16** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Property Name** | **Property Type** | **Area** | **% of Square Feet** | **Annualized<br> Rent ($000's)** | **% of Annualized<br> Rent** | **Population** | **MSA/MISA** | **Rank** |
| Berry Surgical Center | SCH | 27217 | 0.60% | $653 | 0.57% | 4390913 | Detroit-Warren-Dearborn, MI | 14 |
| Smokey Point Behavioral Hospital | AIB | 70100 | 1.55% | $2856.6 | 2.48% | 4161883 | Seattle-Tacoma-Bellevue, WA | 15 |
| Sanford Health Bemidji 1611 | MOB | 45800 | 1.01% | $1616.3 | 1.41% | 3790295 | Minneapolis-St. Paul-Bloomington, MN-WI | 16 |
| Sanford Health Bemidji 1705 | MOB | 28900 | 0.64% | $649.5 | 0.56% | 3790295 | Minneapolis-St. Paul-Bloomington, MN-WI | 16 |
| Bay Area Physicians Center | MOB | 17943 | 0.40% | $421.5 | 0.37% | 3418895 | Tampa-St. Petersburg-Clearwater, FL | 17 |
| Nobis Rehabilitation Hospital | IRF | 37151 | 0.82% | $2654.5 | 2.31% | 3418895 | Tampa-St. Petersburg-Clearwater, FL | 17 |
| Liberty Dialysis | SC | 8450 | 0.19% | $262.9 | 0.23% | 3092037 | Denver-Aurora-Centennial, CO | 19 |
| Bassin Center For Plastic-Surgery-Villages | PC | 2894 | 0.06% | $178.5 | 0.16% | 2957672 | Orlando-Kissimmee-Sanford, FL | 20 |
| Kissimmee Medical Plaza | PC | 4902 | 0.11% | $— | —% | 2957672 | Orlando-Kissimmee-Sanford, FL | 20 |
| PAM Health Rehabilitation Hospital of Ocoee | IRF | 37151 | 0.82% | $2500 | 2.17% | 2957672 | Orlando-Kissimmee-Sanford, FL | 20 |
| Orthopaedic Associates of Osceola | PC | 15167 | 0.33% | $378.7 | 0.33% | 2957672 | Orlando-Kissimmee-Sanford, FL | 20 |
| Medical Village at Wintergarden | MOB | 21532 | 0.47% | $642.8 | 0.56% | 2957672 | Orlando-Kissimmee-Sanford, FL | 20 |
| Waters Edge Medical | MOB | 23388 | 0.52% | $412.8 | 0.36% | 2857781 | Baltimore-Columbia-Towson, MD | 22 |
| Northbay Professional Pavilion | MOB | 19656 | 0.43% | $488.3 | 0.42% | 2857781 | Baltimore-Columbia-Towson, MD | 22 |
| Righttime Medical Care | SC | 6236 | 0.14% | $359.5 | 0.31% | 2857781 | Baltimore-Columbia-Towson, MD | 22 |
| Belleville Medical Office | PC | 6487 | 0.14% | $— | —% | 2814421 | St. Louis, MO-IL | 23 |
| Eyecare Partners - 1310 | PC | 5560 | 0.12% | $55.5 | 0.05% | 2814421 | St. Louis, MO-IL | 23 |
| Eyecare Partners - 3990 | SCH | 16608 | 0.37% | $310.6 | 0.27% | 2814421 | St. Louis, MO-IL | 23 |
| Eyecare Partners - 204 | PC | 6311 | 0.14% | $52 | 0.05% | 2814421 | St. Louis, MO-IL | 23 |
| Heartland Women's Healthcare of Advantia Shiloh | PC | 16212 | 0.36% | $366.6 | 0.32% | 2814421 | St. Louis, MO-IL | 23 |
| Heartland Women's Healthcare of Advantia Wentzville | PC | 7900 | 0.17% | $140.4 | 0.12% | 2814421 | St. Louis, MO-IL | 23 |
| Baptist Health | PC | 13500 | 0.30% | $387.5 | 0.34% | 2813140 | San Antonio-New Braunfels, TX | 24 |
| San Antonio Head & Neck Surgical Associates | PC | 6500 | 0.14% | $195.5 | 0.17% | 2813140 | San Antonio-New Braunfels, TX | 24 |
| Rehabilitation Institute of South San Antonio | IRF | 38000 | 0.84% | $2170.6 | 1.89% | 2813140 | San Antonio-New Braunfels, TX | 24 |
| JDH Professional Building | MOB | 12376 | 0.27% | $264.5 | 0.23% | 2813140 | San Antonio-New Braunfels, TX | 24 |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 17** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Property Name** | **Property Type** | **Area** | **% of Square Feet** | **Annualized<br> Rent ($000's)** | **% of Annualized<br> Rent** | **Population** | **MSA/MISA** | **Rank** |
| The Heart & Vascular Center | PC | 15878 | 0.35% | $323.4 | 0.28% | 2421992 | Pittsburgh, PA | 28 |
| Butler Medical Center | MOB | 10116 | 0.22% | $172.5 | 0.15% | 2421992 | Pittsburgh, PA | 28 |
| Forefront Dermatology Building | PC | 15650 | 0.35% | $357.9 | 0.31% | 2421992 | Pittsburgh, PA | 28 |
| Greentree Primary Care | MOB | 33715 | 0.74% | $1052.3 | 0.92% | 2421992 | Pittsburgh, PA | 28 |
| Vascular Access Centers of Southern Nevada | SC | 4800 | 0.11% | $127.5 | 0.11% | 2407226 | Las Vegas-Henderson-North Las Vegas, NV | 29 |
| Assurance Health System - 11690 | BSF | 14381 | 0.32% | $588.7 | 0.51% | 2312858 | Cincinnati, OH-KY-IN | 30 |
| Cavalier Medical & Dialysis Center | MOB | 17614 | 0.39% | $224.9 | 0.20% | 2312858 | Cincinnati, OH-KY-IN | 30 |
| 51 Cavalier Blvd | MOB | 17935 | 0.40% | $226.4 | 0.20% | 2312858 | Cincinnati, OH-KY-IN | 30 |
| Anderson Ferry Plaza | MOB | 43791 | 0.97% | $654.1 | 0.57% | 2312858 | Cincinnati, OH-KY-IN | 30 |
| Liberty Rehabilitation Hospital | IRF | 37720 | 0.83% | $2518.8 | 2.19% | 2312858 | Cincinnati, OH-KY-IN | 30 |
| Florence Medical Building | MOB | 17845 | 0.39% | $262.2 | 0.23% | 2312858 | Cincinnati, OH-KY-IN | 30 |
| Prairie Star Medical Facility I | MOB | 24724 | 0.55% | $648.1 | 0.56% | 2270682 | Kansas City, MO-KS | 31 |
| Prairie Star Medical Facility II | MOB | 24840 | 0.55% | $291.5 | 0.25% | 2270682 | Kansas City, MO-KS | 31 |
| Ravines Edge | MOB | 16751 | 0.37% | $95.1 | 0.08% | 2242028 | Columbus, OH | 32 |
| Hope Valley Recovery - Circleville | BSF | 7787 | 0.17% | $88.5 | 0.08% | 2242028 | Columbus, OH | 32 |
| Hopebridge - Columbus | BSF | 13969 | 0.31% | $177.4 | 0.15% | 2242028 | Columbus, OH | 32 |
| Sedalia Medical Center | MOB | 19426 | 0.43% | $347.9 | 0.30% | 2242028 | Columbus, OH | 32 |
| Assurance Health, LLC | BSF | 10200 | 0.22% | $395.3 | 0.34% | 2205695 | Indianapolis-Carmel-Greenwood, IN | 33 |
| Assurance Health System - 900 | BSF | 13722 | 0.30% | $538.0 | 0.47% | 2205695 | Indianapolis-Carmel-Greenwood, IN | 33 |
| Kindred Hospital Indianapolis North | LTACH | 37270 | 0.82% | $1652.4 | 1.44% | 2205695 | Indianapolis-Carmel-Greenwood, IN | 33 |
| Brook Park Medical Building | MOB | 18444 | 0.41% | $39.1 | 0.03% | 2165775 | Cleveland, OH | 35 |
| Smith Road | MOB | 16802 | 0.37% | $334.7 | 0.29% | 2165775 | Cleveland, OH | 35 |
| Assurance - Hudson | BSF | 13290 | 0.29% | $601.7 | 0.52% | 2165775 | Cleveland, OH | 35 |
| Rockside Medical Center | MOB | 55316 | 1.22% | $624.3 | 0.54% | 2165775 | Cleveland, OH | 35 |
| Virginia Orthopaedic & Spine Specialists | PC | 8445 | 0.19% | $159.3 | 0.14% | 1797213 | Virginia Beach-Chesapeake-Norfolk, VA-NC | 37 |
| LTAC Hospital of SE Massachusetts | LTACH | 70657 | 1.56% | $659.4 | 0.57% | 1708161 | Providence-Warwick, RI-MA | 39 |
| Warwick Oncology Center | SC | 10236 | 0.23% | $325.3 | 0.28% | 1708161 | Providence-Warwick, RI-MA | 39 |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 18** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Property Name** | **Property Type** | **Area** | **% of Square Feet** | **Annualized<br> Rent ($000's)** | **% of Annualized<br> Rent** | **Population** | **MSA/MISA** | **Rank** |
| South County Hospital | PC | 13268 | 0.29% | $330.4 | 0.29% | 1708161 | Providence-Warwick, RI-MA | 39 |
| Mercy Rehabilitation Hospital | IRF | 39637 | 0.87% | $2109.9 | 1.83% | 1512813 | Oklahoma City, OK | 42 |
| Memphis Center | MOB | 11669 | 0.26% | $241.7 | 0.21% | 1341412 | Memphis, TN-MS-AR | 45 |
| Sanderling Dialysis Center - 7710 | SC | 10133 | 0.22% | $584.8 | 0.51% | 1341412 | Memphis, TN-MS-AR | 45 |
| Gardendale MOB | MOB | 12956 | 0.29% | $333 | 0.29% | 1197766 | Birmingham, AL | 48 |
| Sanford West Behavioral Facility | BSF | 96886 | 2.14% | $1421.3 | 1.24% | 1183645 | Grand Rapids-Wyoming-Kentwood, MI | 49 |
| Glastonbury | MOB | 48375 | 1.07% | $955.3 | 0.83% | 1171426 | Hartford-West Hartford-East Hartford, CT | 50 |
| Sterling Medical Center | MOB | 28478 | 0.63% | $525.4 | 0.46% | 1155653 | Buffalo-Cheektowaga, NY | 51 |
| Los Alamos Professional Plaza | MOB | 43395 | 0.96% | $427.4 | 0.37% | 921549 | McAllen-Edinburg-Mission, TX | 64 |
| UMass Memorial Health Cancer Center | SC | 20046 | 0.44% | $855.3 | 0.74% | 888502 | Worcester, MA | 68 |
| Worcester Behavioral | AIB | 81972 | 1.81% | $2772.2 | 2.41% | 888502 | Worcester, MA | 68 |
| El Paso Rehabilitation Hospital | IRF | 38000 | 0.84% | $2203.1 | 1.92% | 881291 | El Paso, TX | 70 |
| Columbia Gastroenterology Surgery Center | PC | 17016 | 0.38% | $349.8 | 0.30% | 879918 | Columbia, SC | 71 |
| Genesis Care - Bonita Springs | SC | 4445 | 0.10% | $304.6 | 0.26% | 875607 | Cape Coral-Fort Myers, FL | 72 |
| Cape Coral Suite 3 | SC | 12130 | 0.27% | $477.8 | 0.42% | 875607 | Cape Coral-Fort Myers, FL | 72 |
| Cape Coral Suite 3A | MOB | 2023 | 0.04% | $41.4 | 0.04% | 875607 | Cape Coral-Fort Myers, FL | 72 |
| Cape Coral Suite 5 & 6 | MOB | 6379 | 0.14% | $104.3 | 0.09% | 875607 | Cape Coral-Fort Myers, FL | 72 |
| Corporate Office 3660 | MOB | 22104 | 0.49% | $658.3 | 0.57% | 875607 | Cape Coral-Fort Myers, FL | 72 |
| Corporate Annex Building | MOB | 16000 | 0.35% | $329 | 0.29% | 875607 | Cape Coral-Fort Myers, FL | 72 |
| Wildwood Hammock RPET Facility | SC | 10832 | 0.24% | $455.2 | 0.40% | 875607 | Cape Coral-Fort Myers, FL | 72 |
| Wildwood Hammock - Diagnostic Imaging | SC | 9376 | 0.21% | $430.4 | 0.37% | 875607 | Cape Coral-Fort Myers, FL | 72 |
| Wildwood Hammock - Northland | MOB | 1201 | 0.03% | $14.4 | 0.01% | 875607 | Cape Coral-Fort Myers, FL | 72 |
| Eye Health of America 4101 | MOB | 43322 | 0.96% | $1026.2 | 0.89% | 875607 | Cape Coral-Fort Myers, FL | 72 |
| Eye Health of America 2665 | MOB | 3200 | 0.07% | $56.5 | 0.05% | 875607 | Cape Coral-Fort Myers, FL | 72 |
| Eye Health of America 1320 | MOB | 6757 | 0.15% | $82 | 0.07% | 875607 | Cape Coral-Fort Myers, FL | 72 |
| Everest Physical Rehabilitation Hospital | IRF | 37151 | 0.82% | $2654.5 | 2.31% | 874790 | Lakeland-Winter Haven, FL | 73 |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 19** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Property Name** | **Property Type** | **Area** | **% of Square Feet** | **Annualized<br> Rent ($000's)** | **% of Annualized<br> Rent** | **Population** | **MSA/MISA** | **Rank** |
| Parkway Professional Plaza | MOB | 41909 | 0.92% | $1014.4 | 0.88% | 874790 | Lakeland-Winter Haven, FL | 73 |
| Davita Turner Road | SC | 18125 | 0.40% | $372.7 | 0.32% | 826554 | Dayton-Kettering-Beavercreek, OH | 76 |
| Davita Springboro Pike | SC | 10510 | 0.23% | $192.4 | 0.17% | 826554 | Dayton-Kettering-Beavercreek, OH | 76 |
| Davita Business Center Court | SC | 12988 | 0.29% | $242.4 | 0.21% | 826554 | Dayton-Kettering-Beavercreek, OH | 76 |
| Mercy One Physicians Clinic | PC | 17318 | 0.38% | $406.2 | 0.35% | 758539 | Des Moines-West Des Moines, IA | 82 |
| Daytona Medical Office | MOB | 20193 | 0.45% | $382.3 | 0.33% | 746933 | Deltona-Daytona Beach-Ormond Beach, FL | 83 |
| Debary Professional Plaza | MOB | 21361 | 0.47% | $325.4 | 0.28% | 746933 | Deltona-Daytona Beach-Ormond Beach, FL | 83 |
| UW Health Clinic- Portage | PC | 14000 | 0.31% | $342.3 | 0.30% | 709685 | Madison, WI | 86 |
| Novus Clinic | SCH | 14315 | 0.32% | $309.8 | 0.27% | 701780 | Akron, Oh | 87 |
| Aurora Health Center | PC | 15650 | 0.35% | $344.3 | 0.30% | 701780 | Akron, Oh | 87 |
| Bassin Center For Plastic Surgery-Melbourne | PC | 5228 | 0.12% | $322.5 | 0.28% | 663982 | Palm Bay-Melbourne-Titusville, FL | 89 |
| Cypress Medical Center | MOB | 37428 | 0.83% | $465.7 | 0.40% | 663809 | Wichita, KS | 90 |
| Family Medicine East | PC | 16581 | 0.37% | $— | —% | 663809 | Wichita, KS | 90 |
| Wichita Medical Clinic | PC | 18681 | 0.41% | $— | —% | 663809 | Wichita, KS | 90 |
| Mercy Rehabilitation Hospital - Northwest Arkansas | IRF | 38817 | 0.86% | $2296.1 | 2.00% | 622177 | Fayetteville-Springdale-Rogers, AR | 94 |
| Pennsylvania Gastroenterology | PC | 20400 | 0.45% | $605.0 | 0.53% | 617427 | Harrisburg-Carlisle, PA | 95 |
| Penn State Health - Camp Hill | SC | 8400 | 0.19% | $— | —% | 617427 | Harrisburg-Carlisle, PA | 95 |
| Penn State Health - Harrisburg | SC | 10000 | 0.22% | $200.9 | 0.17% | 617427 | Harrisburg-Carlisle, PA | 95 |
| Perrysburg Medical Arts Building | MOB | 26585 | 0.59% | $507.4 | 0.44% | 599376 | Toledo, OH | 98 |
| Sunforest Ct Medical Center | MOB | 23368 | 0.52% | $339.3 | 0.30% | 599376 | Toledo, OH | 98 |
| Assurance - Toledo | BSF | 13290 | 0.29% | $565.4 | 0.49% | 599376 | Toledo, OH | 98 |
| Granite Circle | MOB | 17164 | 0.38% | $244.2 | 0.21% | 599376 | Toledo, OH | 98 |
| Cardiology Associates of Greater Waterbury | PC | 16793 | 0.37% | $348.5 | 0.30% | 578741 | New Haven, CT | 100 |
| Riverview Medical Center | MOB | 26427 | 0.58% | $798.4 | 0.69% | 574418 | Scranton--Wilkes-Barre, PA | 103 |
| NEI - 200 | MOB | 22743 | 0.50% | $409.4 | 0.36% | 574418 | Scranton--Wilkes-Barre, PA | 103 |
| NEI - 204 | MOB | 15768 | 0.35% | $236.4 | 0.21% | 574418 | Scranton--Wilkes-Barre, PA | 103 |
| Treasure Coast Medical Pavilion | MOB | 55844 | 1.23% | $927.6 | 0.81% | 568721 | Port St. Lucie, FL | 104 |
| Grandview Plaza | MOB | 20042 | 0.44% | $319.8 | 0.28% | 563159 | Lancaster, PA | 105 |
| Pinnacle Health | PC | 10753 | 0.24% | $250.0 | 0.22% | 563159 | Lancaster, PA | 105 |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 20** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Property Name** | **Property Type** | **Area** | **% of Square Feet** | **Annualized<br> Rent ($000's)** | **% of Annualized<br> Rent** | **Population** | **MSA/MISA** | **Rank** |
| Manteca Medical Group Building | MOB | 10519 | 0.23% | $328.9 | 0.29% | 557719 | Modesto, CA | 106 |
| Gulf Coast Cancer Centers-Brewton | SC | 3971 | 0.09% | $— | —% | 556444 | Huntsville, AL | 107 |
| Martin Foot & Ankle Clinic | PC | 27100 | 0.60% | $440.4 | 0.38% | 473197 | York-Hanover, PA | 116 |
| Lafayette Behavioral | BSF | 31650 | 0.70% | $1684.9 | 1.47% | 423758 | Lafayette, LA | 132 |
| UPMC Specialty Care | MOB | 25982 | 0.57% | $453.4 | 0.39% | 423678 | Youngstown-Warren, OH | 133 |
| Biltmore Medical Office | SC | 11099 | 0.24% | $222.4 | 0.19% | 422345 | Asheville, NC | 134 |
| Genesis Care - Weaverville | SC | 10696 | 0.24% | $480 | 0.42% | 422345 | Asheville, NC | 134 |
| Belden Medical Arts Building | MOB | 47366 | 1.04% | $506.7 | 0.44% | 400246 | Canton-Massillon, OH | 140 |
| Hills & Dales Professional Center | MOB | 27920 | 0.62% | $351.6 | 0.31% | 400246 | Canton-Massillon, OH | 140 |
| Prattville Town Center Medical Office Bldg | MOB | 13319 | 0.29% | $275.5 | 0.24% | 388747 | Montgomery, AL | 145 |
| Bluewater Orthopedics Center | MOB | 10255 | 0.23% | $223.8 | 0.19% | 315098 | Crestview-Fort Walton Beach-Destin, FL | 168 |
| Wellmont Bristol Urgent Care | SC | 4548 | 0.10% | $78.5 | 0.07% | 314834 | Kingsport-Bristol, TN-VA | 169 |
| Steeles Road Medical Building | PC | 10804 | 0.24% | $164.8 | 0.14% | 314834 | Kingsport-Bristol, TN-VA | 169 |
| Londonderry Centre | MOB | 21203 | 0.47% | $382.5 | 0.33% | 308807 | Waco, TX | 171 |
| Westlake Medical Office | MOB | 14100 | 0.31% | $243.1 | 0.21% | 308807 | Waco, TX | 171 |
| Longview Rehabilitation Hospital | IRF | 38817 | 0.86% | $2349.2 | 2.04% | 297315 | Longview, TX | 173 |
| Gulf Coast Cancer Centers-Foley | SC | 6146 | 0.14% | $178.2 | 0.16% | 267761 | Daphne-Fairhope-Foley, AL | 189 |
| Gulf Shores Building | SC | 6398 | 0.14% | $51.3 | 0.04% | 267761 | Daphne-Fairhope-Foley, AL | 189 |
| Monroe Surgical Hospital | SCH | 58121 | 1.28% | $2535.5 | 2.21% | 222390 | Monroe, LA | 217 |
| Ft. Valley Dialysis Center | SC | 4920 | 0.11% | $87 | 0.08% | 208091 | Warner Robins, GA | 228 |
| Meridian Behavioral Health Systems | AIB | 132430 | 2.92% | $3263.5 | 2.84% | 200170 | Charleston, WV | 233 |
| Tuscola Professional Building | MOB | 25500 | 0.56% | $622.4 | 0.54% | 187688 | Saginaw, MI | 241 |
| Kedplasma | SC | 12870 | 0.28% | $272.1 | 0.24% | 186177 | Burlington, NC | 243 |
| Redding Oncology Center | SC | 12206 | 0.27% | $585.9 | 0.51% | 181648 | Redding, CA | 249 |
| Decatur Morgan Hospital Medical Office Building | MOB | 35933 | 0.79% | $582.4 | 0.51% | 160326 | Decatur, AL | 272 |
| Bourbonnais Medical Center | MOB | 54894 | 1.21% | $617.1 | 0.54% | 105525 | Kankakee, IL | 351 |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 21** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Property Name** | **Property Type** | **Area** | **% of Square Feet** | **Annualized<br> Rent ($000's)** | **% of Annualized<br> Rent** | **Population** | **MSA/MISA** | **Rank** |
| Parkside Family & Davita Clinics | MOB | 15637 | 0.34% | $222.2 | 0.19% | 99864 | Victoria, TX | 363 |
| Cub Lake Square | MOB | 48756 | 1.07% | $1043.8 | 0.91% | 109946 | Show Low, AZ | n/a |
| Emory Healthcare - 303 | MOB | 61301 | 1.35% | $952.6 | 0.83% | 107097 | LaGrange, GA-AL | n/a |
| Emory Southern Orthopedics - 1805 | MOB | 31473 | 0.69% | $733.5 | 0.64% | 107097 | LaGrange, GA-AL | n/a |
| Emory Southern Orthopedics - 1801 | MOB | 2972 | 0.07% | $62.7 | 0.05% | 107097 | LaGrange, GA-AL | n/a |
| Emory Healthcare - 1610 | MOB | 5600 | 0.12% | $87 | 0.08% | 107097 | LaGrange, GA-AL | n/a |
| Nesbitt Place | MOB | 56003 | 1.23% | $1074.8 | 0.93% | 83911 | Lawrence County, PA | n/a |
| Davita Etowah Dialysis Center | SC | 4720 | 0.10% | $71.6 | 0.06% | 71590 | Athens, TN | n/a |
| Marion Medical Plaza | MOB | 27246 | 0.60% | $390.3 | 0.34% | 65115 | Marion, OH | n/a |
| Pahrump Medical Plaza | MOB | 12545 | 0.28% | $479.5 | 0.42% | 57336 | Pahrump, NV | n/a |
| Corsicana Medical Plaza | MOB | 17746 | 0.39% | $373.2 | 0.32% | 57181 | Corsicana, TX | n/a |
| Arkansas Valley Surgery Center | MOB | 10717 | 0.24% | $235.3 | 0.20% | 50039 | Cañon City, CO | n/a |
| Baylor Scott & White Clinic | PC | 37354 | 0.82% | $505.8 | 0.44% | 38288 | Brenham, TX | n/a |
| Fremont Medical Office Building & Surgery Ctr | MOB | 13050 | 0.29% | $345.8 | 0.30% | 38057 | Fremont, NE | n/a |
| Eyecare Partners - 408 | PC | 8421 | 0.19% | $134.3 | 0.12% | 36382 | Centralia, IL | n/a |
| Ottumwa Medical Clinic - 1005 | MOB | 68895 | 1.52% | $747.2 | 0.65% | 35210 | Ottumwa, IA | n/a |
| Ottumwa Medical Clinic - 1007 | MOB | 6850 | 0.15% | $96.2 | 0.08% | 35210 | Ottumwa, IA | n/a |
| Fresenius Gallipolis Dialysis Center | SC | 15110 | 0.33% | $160.2 | 0.14% | 29072 | Gallipolis, OH | n/a |
| Princeton Cancer Center | SC | 7236 | 0.16% | $204.4 | 0.18% | County: 57,454 | Rural - No CBSA | n/a |
| Sanderling Dialysis Center - 102 | SC | 5217 | 0.12% | $295.6 | 0.26% | County: 57,454 | Rural - No CBSA | n/a |
| Andalusia Medical Plaza | SC | 10373 | 0.23% | $297.7 | 0.26% | County: 37,750 | Rural - No CBSA | n/a |
| Sanderling Dialysis Center - 780 | SC | 4186 | 0.09% | $320.4 | 0.28% | County: 37,750 | Rural - No CBSA | n/a |
| North Mississippi Health Services - 1107 | MOB | 17629 | 0.39% | $99.8 | 0.09% | County: 33,928 | Rural - No CBSA | n/a |
| North Mississippi Health Services - 1111 | MOB | 27743 | 0.61% | $157.1 | 0.14% | County: 33,928 | Rural - No CBSA | n/a |
| North Mississippi Health Services - 1127 | MOB | 18074 | 0.40% | $102.3 | 0.09% | County: 33,928 | Rural - No CBSA | n/a |
| North Mississippi Health Services - 404 | MOB | 9890 | 0.22% | $56 | 0.05% | County: 33,928 | Rural - No CBSA | n/a |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 22** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Property Name** | **Property Type** | **Area** | **% of Square Feet** | **Annualized<br> Rent ($000's)** | **% of Annualized<br> Rent** | **Population** | **MSA/MISA** | **Rank** |
| North Mississippi Health Services - 305 | MOB | 3378 | 0.07% | $19.1 | 0.02% | County: 33,928 | Rural - No CBSA | n/a |
| Sanderling Dialysis Center - 2102 | SC | 11300 | 0.25% | $450.1 | 0.39% | County: 33,928 | Rural - No CBSA | n/a |
| Batesville Regional Medical Center | MOB | 9263 | 0.20% | $52.5 | 0.05% | County: 32,965 | Rural - No CBSA | n/a |
| Tri Lakes Behavioral | BSF | 58400 | 1.29% | $— | —% | County: 32,965 | Rural - No CBSA | n/a |
| Dahlonega Medical Mall | MOB | 22805 | 0.50% | $399.3 | 0.35% | County: 33,362 | Rural - No CBSA | n/a |
| Russellville Medical Plaza | MOB | 29129 | 0.64% | $173.1 | 0.15% | County: 31,870 | Rural - No CBSA | n/a |
| Norton Medical Plaza | MOB | 32757 | 0.72% | $276.5 | 0.24% | County: 25,635 | Rural - No CBSA | n/a |
| Wellmont Lebanon Urgent Care | SC | 8369 | 0.18% | $108.8 | 0.09% | County: 22,951 | Rural - No CBSA | n/a |
| Lexington Carilion Clinic | PC | 15820 | 0.35% | $392.0 | 0.34% | County: 22,573 | Rural - No CBSA | n/a |
| Norton Medical Clinic | SC | 4843 | 0.11% | $60.3 | 0.05% | County: 13,464 | Rural - No CBSA | n/a |

---

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 23** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**REPORTING DEFINITIONS**

    

**Acute Inpatient Behavioral Facilities (AIB)**

Behavioral inpatient acute care facilities are healthcare facilities that provide a range of clinical services for mental health and/or substance abuse diagnoses on an inpatient basis. Behavioral health services provided may include assessment, treatment, individual medical evaluation and management (including medication management), individual and group therapy, behavioral health counseling, family therapy and psychological testing for recipients of all ages.

**AFFO, Adjusted for Acquisitions**

AFFO, Adjusted for Acquisitions, adjusts AFFO to show the impact of the real estate properties acquired in the period as if they had been acquired on the first day of the reporting period, using the expected returns and in-place leases at the time of the acquisition. The Company believes that AFFO, Adjusted for Acquisitions, is useful because it allows investors, analysts and Company management visibility into the impact on the Company's results of operations in future reporting periods resulting from its current period acquisitions.

**Annualized Rent**

Annualized and stabilized base rent for leases in place at the end of the period multiplied by 12.

**Behavioral Specialty Facilities (BSF)**

Behavioral specialty facilities are healthcare facilities that provide a range of clinical services for mental health and/or substance abuse diagnoses. Behavioral health services provided may include assessment, treatment, individual medical evaluation and management (including medication management), individual and group therapy, behavioral health counseling, family therapy and psychological testing for recipients of all ages.

**EBITDA*re* and Adjusted EBITDA*re***

The Company uses the National Association of Real Estate Investment Trusts, Inc. ("NAREIT") definition of EBITDA*re* which is net income plus interest expense, income tax expense, and depreciation and amortization, plus losses or minus gains on the disposition of depreciable property, including losses/gains on change of control, plus impairment write-downs of depreciable property and of investments in unconsolidated affiliates caused by a decrease in value of depreciable property in the affiliate, plus or minus adjustments to reflect the entity's share of EBITDA*re* of unconsolidated affiliates and consolidated affiliates with non-controlling interest. The Company also presents Adjusted EBITDA*re* which is EBITDA*re* before non-cash stock-based compensation amortization.

We consider EBITDA*re* and Adjusted EBITDA*re* important measures because they provide additional information to allow management, investors, and our current and potential creditors to evaluate and compare our core operating results and our ability to service debt.

**Funds from Operations (FFO) and Adjusted Funds from Operations (AFFO)**

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or fallen with market conditions, many industry investors deem presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. For that reason, the Company considers funds from operations ("FFO") and adjusted funds from operations ("AFFO") to be appropriate measures of operating performance of an equity real estate investment trust ("REIT"). In particular, the Company believes that AFFO is useful because it allows investors, analysts and Company management to compare the Company's operating performance to the operating performance of other real estate companies and between periods on a consistent basis without having to account for differences caused by unanticipated items and other events.

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 24** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**REPORTING DEFINITIONS (continued)**

    

The Company uses the NAREIT definition of FFO. FFO is an operating performance measure adopted by NAREIT. NAREIT defines FFO as the most commonly accepted and reported measure of a REIT's operating performance equal to net income (calculated in accordance with GAAP), excluding gains or losses from the sale of certain real estate assets, gains and losses from change in control, impairment write-downs of certain real estate assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity, plus depreciation and amortization related to real estate properties, and after adjustments for unconsolidated partnerships and joint ventures. NAREIT also provides REITs with an option to exclude gains, losses and impairments of assets that are incidental to the main business of the REIT from the calculation of FFO. The Company has included AFFO which it has defined as FFO, excluding certain expenses related to closing costs of properties acquired accounted for as business combinations and mortgages funded, excluding straight-line rent and the amortization of stock-based compensation, and including or excluding other non-cash items from time to time. AFFO presented herein may not be comparable to similar measures presented by other real estate companies due to the fact that not all real estate companies use the same definition.

FFO and AFFO should not be considered as alternatives to net income (determined in accordance with GAAP) as indicators of the Company's financial performance or as alternatives to cash flow from operating activities

(determined in accordance with GAAP) as measures of the Company's liquidity, nor are they necessarily indicative of sufficient cash flow to fund all of the Company's needs. The Company believes that in order to facilitate a clear understanding of the consolidated historical operating results of the Company, FFO and AFFO should be examined in conjunction with net income as presented elsewhere herein.

**Inpatient Rehabilitation Facilities (IRF)**

Inpatient rehabilitation facilities are free standing rehabilitation hospitals, or may be units within an acute care hospital, that provide intensive rehabilitation programs to patients.

**Long-Term Acute Care Hospitals (LTACH)**

Long-term acute care hospitals provide inpatient services for patients with complex medical conditions who require more sensitive care, monitoring or emergency support than that available in most skilled nursing facilities.

**Medical Office Building (MOB)** 

Medical office buildings are buildings occupied by healthcare providers and may be located near hospitals or other facilities where healthcare services are rendered or in close proximity to a population base. Medical office buildings can be leased to physicians, physician practice groups, hospitals, healthcare systems or other healthcare providers.

**Metropolitan Statistical Area (MSA or MISA)**

MSAs or MISAs are geographical regions with relatively higher population densities at their core and have close economic ties throughout their area. MSAs and MISAs are defined by the Office of Management and Budget.

**Net Operating Income (NOI)**

NOI is a non-GAAP financial measure that is defined as net income or loss, computed in accordance with GAAP, generated from our total portfolio of properties and other investments before general and administrative expenses, depreciation and amortization expense, gains or loss on the sale of real estate properties or other investments, interest expense, and income tax expense. We believe that NOI provides an accurate measure of operating performance of our operating assets because NOI excludes certain items that are not associated with management of the properties. CHCT's use of the term NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing NOI.

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 25** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**REPORTING DEFINITIONS (continued)**

    

**Physician Clinics (PC)** 

Physician clinics are freestanding healthcare facilities that are primarily devoted to the care of ambulatory patients, can be privately operated or publicly managed and funded, and typically provide primary healthcare needs of populations in local communities utilizing physicians and other healthcare providers.

**Specialty Centers (SC)**

Specialty centers include various types of centers which may, among others, include oncology centers, dialysis centers, urgent care centers, and blood plasma centers.

**Surgical Centers and Hospitals (SCH)**

Surgical centers and hospitals may include outpatient surgery centers where surgical procedures not requiring an overnight hospital stay are performed; as well as specialty hospitals that focus on providing care for certain conditions and performing certain procedures, such as cardiovascular and orthopedic surgery.

**Total Capitalization**

Debt plus stockholders' equity plus accumulated depreciation.

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 26** | **1Q 2026 \| Supplemental Information** |

---

------

![chctlogo.jpg](chctlogo.jpg)<br>

**DISCLAIMERS**

    

**FORWARD-LOOKING STATEMENTS**

    

Certain statements made in this supplemental information package constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (set forth in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act")). In particular, statements pertaining to our capital resources, portfolio performance and results of operations contain forward-looking statements. Likewise, our statements regarding anticipated market conditions are forward-looking statements. You can identify forward-looking statements by the use of forward-looking terminology such as "believes," "expects," "may," "will," "should," "seeks," "approximately," "intends," "plans," "outlook," "continue," "projects," "estimates" or "anticipates" or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans, expectations, or intentions.

Forward-looking statements reflect the views of our management regarding current expectations and projections about future events and are based on currently available information. These forward-looking statements are not guarantees of future performance and involve numerous risks and uncertainties and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data, or methods which may be incorrect or imprecise and we may not be able to realize them.

While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. We disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, of new information, data or methods, future events or other changes after the date of this supplemental information package, except as required by applicable law. You should not place undue reliance on any forward-looking statements that are based on information currently available to us or the third parties making the forward-looking statements. For a discussion of factors that could impact our future results, performance or transactions, see Part I, Item 1A (Risk Factors) of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and the Company's other filings with the Securities and Exchange Commission from time to time.

**NON-GAAP FINANCIAL MEASURES** 

    

This presentation includes EBITDA*re*, Adjusted EBITDA*re*, Adjusted EBITDA*re* Annualized, Net Operating Income (or NOI), Funds From Operations (or FFO), Adjusted Funds From Operations (or AFFO), and AFFO, Adjusted for Acquisitions, which are non-GAAP financial measures. For purposes of the Securities and Exchange Commission's ("SEC") Regulation G, a non-GAAP financial measure is a numerical measure of a company's historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable financial measure calculated and presented in accordance with GAAP in the statements of operations, balance sheets or statements of cash flows (or equivalent statements) of the company, or includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable financial measure so calculated and presented. As used in this presentation, GAAP refers to generally accepted accounting principles in the United States of America. Our use of the non-GAAP financial measure terms herein may not be comparable to that of other real estate investment trusts. Pursuant to the requirements of Regulation G, we have provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.

---

| | | |
|:---|:---|:---|
| **Community Healthcare Trust** | **Page \| 27** | **1Q 2026 \| Supplemental Information** |

---